TED Ted Baker Plc

RNS Number:5904G
Tepnel Life Sciences PLC
24 July 2006












FOR IMMEDIATE RELEASE




Tepnel Life Sciences plc ('Tepnel' or 'the Company')


Tepnel signs Quality Agreement with Pfizer Ltd for CGMP Services


Manchester, UK, 24th July, 2006 - Tepnel Life Sciences PLC (AIM: TED), the UK-
based international Molecular Diagnostics and Research Products & Services
group, is pleased to announce that it's Scottish pharmaceutical services
subsidiary, Tepnel Scientific Services Ltd, has entered into a quality agreement
with Pfizer, one of the world's leading pharmaceutical companies.  Under the
scope of this agreement Tepnel has been selected as a supplier to Pfizer for
analytical chemistry and microbiological services.  By continuing to provide a
high quality service, Tepnel expects to have the opportunity to tender for
further Pfizer business.



Following Tepnel's recent placing which will, in part, fund the completion of
its 18,000 sq ft analytical testing facility in Scotland, Ben Matzilevich, CEO,
commented: "We are delighted to announce this agreement with Pfizer which is
proof of the high level of quality and regulatory compliance our systems
provide. This agreement further strengthens Tepnel's position in the analytical
outsourcing marketplace as a provider of regulatory compliant services to the
pharmaceutical industry."




About Tepnel Life Sciences plc



Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two main divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees.  TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research.  The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets.  TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.



More information on Tepnel can be found at www.tepnel.com.





Tepnel Life Sciences plc
Ben Matzilevich, CEO

0161 946 2200



De Facto Communications

Richard Anderson

020 7861 3838





Notes to Editors

About Tepnel Life Sciences plc

Tepnel is a UK-based international life sciences company focused on molecular
diagnostics and research products and services including DNA purification kits
and reagents, scientific services for nucleic acid purification, drug analysis,
genotyping and genetically modified foods. Tepnel was founded in 1992 to exploit
DNA technology generated at UMIST (University of Manchester Institute of Science
and Technology) and is quoted on the AIM segment of the London Stock Exchange
(AIM: TED). More information on Tepnel can be found at www.tepnel.com.






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGRAKDKPABKDPOB

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024